中国P站

Antigen Presentation; MHC Molecules; T Cell Activation; Dendritic Cells; Cross-Presentation; HLA Complex; Immunoproteasome; TAP Transporter; Adaptive Immunity; Immune Surveillance

Introduction

Antigen presentation is a cornerstone of adaptive immunity, a complex process involving the meticulous processing and display of peptide fragments on Major Histocompatibility Complex (MHC) molecules for recognition by T cells [1].

Class I MHC presentation typically deals with endogenous antigens that are processed through the proteasome and subsequently transported by the Transporter Associated with Antigen Processing (TAP) to the endoplasmic reticulum for loading onto MHC molecules [1].

Conversely, Class II MHC presentation handles exogenous antigens, which are internalized via endocytosis, processed within endosomes, and then loaded onto MHC II molecules in late endosomes [1].

Significant advancements in recent years have illuminated the diverse mechanisms and a wide array of molecules integral to these processes [1].

This includes the crucial phenomenon of cross-presentation by dendritic cells, a mechanism vital for initiating T cell responses against exogenous antigens, and the emerging understanding of non-peptide antigens in immune recognition [1].

The intricate coordination between the antigen processing machinery, the MHC loading complexes, and the specific cellular context profoundly influences the specificity and overall efficacy of T cell activation [1].

Cross-presentation, a specific and critical pathway, enables the presentation of exogenous antigens on MHC class I molecules, which is paramount for initiating CD8+ T cell responses against viral or tumor antigens that are not produced endogenously [2].

Dendritic cells (DCs) stand out as the principal professional antigen-presenting cells (APCs) responsible for executing cross-presentation, employing specialized cellular pathways to direct exogenous antigens into the MHC class I presentation route [2].

A deep comprehension of the molecular intricacies of these pathways, encompassing the roles of phagosomes, endosomes, and the endoplasmic reticulum, is fundamental for the development of efficacious immunotherapies [2].

The human leukocyte antigen (HLA) complex, which encodes the human MHC molecules, is characterized by extensive polymorphism, thereby contributing to a broad spectrum of antigen presentation capabilities across different individuals [3].

This inherent diversity is not only essential for robust population-level immunity but also poses significant challenges for initiatives such as vaccine development and organ transplantation [3].

Ongoing research continues to meticulously unravel the complex structure-function relationships of various HLA alleles and their profound impact on peptide binding affinity and T cell receptor recognition, progressively refining our understanding of immune surveillance mechanisms and the susceptibility to autoimmune diseases [3].

Non-classical MHC class I molecules, exemplified by HLA-E, assume critical roles in immune regulation by presenting peptides derived from classical MHC class I molecules [4].

This interaction with NKG2 receptors found on Natural Killer (NK) cells and certain T cell populations serves to modulate immune responses and is instrumental in maintaining self-tolerance [4].

Current research is actively expanding the knowledge base regarding the repertoire of peptides presented by non-classical MHC molecules and their functional implications in the context of infection, autoimmunity, and cancer [4].

The immunoproteasome, a specialized variant of the proteasome, plays an indispensable role in generating the precise peptide substrates required for MHC class I presentation [5].

Its catalytic subunits are notably induced by interferons, which fine-tunes its enzymatic activity to produce peptides possessing specific C-terminal residues that exhibit a high affinity for binding to MHC class I molecules [5].

Any disruptions in the functional integrity of the immunoproteasome can significantly impair T cell-mediated immunity and have considerable implications for immune evasion strategies employed by cancer cells and the pathogenesis of autoimmune diseases [5].

The processing and presentation of antigens by dendritic cells (DCs) form the central hub for the initiation of adaptive immune responses [6].

Recent investigations have emphasized the considerable heterogeneity observed among different DC subsets and have elucidated their distinct contributions to antigen presentation, including the specialized functions of conventional DCs (cDCs) and plasmacytoid DCs (pDCs) in presenting viral and self-antigens [6].

The dynamic interplay between DC maturation, their migratory patterns, and the intricate process of antigen loading collectively dictates the ultimate outcome of T cell priming events [6].

The TAP (Transporter Associated with Antigen Processing) complex is absolutely essential for the translocation of antigenic peptides from the cytosol into the endoplasmic reticulum, a prerequisite for their subsequent loading onto MHC class I molecules [7].

The structure and functional intricacies of TAP are highly complex, involving nucleotide-binding domains and transmembrane helices that collectively mediate efficient peptide transport [7].

Recent studies have successfully elucidated the dynamic conformational changes that TAP undergoes and its intricate regulation by accessory proteins, thereby offering invaluable insights into its critical role in immune surveillance and its involvement in various disease states [7].

MHC class II presentation is absolutely vital for orchestrating effective CD4+ T cell responses, which are primarily directed against extracellular pathogens and self-antigens [8].

This sophisticated process involves the uptake of antigens, their subsequent proteolytic degradation within endosomes, and the loading of peptides onto MHC class II molecules, a process critically mediated by the invariant chain (Ii) and its sequential processing into CLIP [8].

Current research is actively uncovering novel regulatory molecules and accessory factors implicated in this pathway, including the pivotal role of lysosomes and endosomal maturation in the generation of immunodominant epitopes [8].

The discovery of CLIP (Class II-associated invariant chain peptide) and the subsequent understanding of its removal by HLA-DM have been pivotal breakthroughs in comprehending the mechanisms governing MHC class II peptide loading [9].

HLA-DM functions as a critical peptide editor, facilitating the exchange of CLIP for antigenic peptides to optimize the presentation of peptides on MHC class II molecules [9].

Recent investigations are focused on exploring the structural dynamics of HLA-DM and its complex interactions with MHC class II molecules, thereby providing a deeper and more mechanistic understanding of this crucial process [9].

The stringent quality control mechanisms that govern MHC class I folding and peptide loading within the endoplasmic reticulum are indispensable for the establishment of efficient T cell immunity [10].

Molecular chaperones, such as calnexin and calreticulin, alongside the tapasin-associated complex, play crucial roles in ensuring that only peptides exhibiting appropriate binding affinity are successfully loaded onto nascent MHC class I molecules [10].

Any dysregulation of these intricate quality control pathways can lead to significant immune deficiencies or the development of autoimmune conditions [10].

Description

Antigen presentation is a fundamental immunological process that underpins adaptive immunity, involving the intricate steps of processing and displaying peptide fragments on MHC molecules for T cell recognition [1].

For Class I MHC presentation, endogenous antigens are typically processed via the proteasome and then transported by TAP to the ER for loading [1].

In contrast, Class II MHC presentation involves exogenous antigens that are taken up through endocytosis, processed in endosomes, and loaded onto MHC II in late endosomes [1].

Recent scientific endeavors have shed light on the diverse mechanisms and numerous molecules involved in these critical pathways, including the significant role of cross-presentation by dendritic cells in initiating T cell responses to exogenous antigens, and the emerging importance of non-peptide antigens [1].

The precise interplay between the antigen processing machinery, MHC loading complexes, and the specific cellular environment is paramount in dictating the specificity and effectiveness of T cell activation [1].

Cross-presentation, a specialized process where exogenous antigens are presented on MHC class I molecules, is indispensable for initiating CD8+ T cell responses against viral or tumor antigens that are not produced internally [2].

Dendritic cells are recognized as the primary professional APCs that perform cross-presentation, utilizing specialized cellular pathways to direct exogenous antigens into the MHC class I presentation pathway [2].

Understanding the detailed molecular mechanisms of these pathways, including the functions of phagosomes, endosomes, and the ER, is essential for the development of effective immunotherapies [2].

The human leukocyte antigen (HLA) complex, which encodes MHC molecules, is exceptionally polymorphic, contributing to a wide range of antigen presentation capabilities among individuals [3].

This genetic diversity is vital for population-level immunity but also presents hurdles for vaccine design and transplantation procedures [3].

Contemporary research continues to meticulously explore the complex relationships between the structure and function of various HLA alleles and their influence on peptide binding and T cell receptor recognition, thereby enhancing our understanding of immune surveillance and susceptibility to autoimmune diseases [3].

Non-classical MHC class I molecules, such as HLA-E, play critical regulatory roles in immunity by presenting peptides derived from classical MHC class I molecules [4].

This interaction with NKG2 receptors on NK cells and certain T cells modulates immune responses and helps maintain self-tolerance [4].

Research is actively expanding to encompass the spectrum of peptides presented by non-classical MHC molecules and their functional consequences in infections, autoimmune disorders, and cancer [4].

The immunoproteasome, a specialized proteasome variant, is crucial for generating the optimal peptide substrates for MHC class I presentation [5].

Its catalytic subunits are induced by interferons, which modifies its activity to produce peptides with specific C-terminal residues that favor binding to MHC class I molecules [5].

Impairments in immunoproteasome function can compromise T cell immunity and have significant implications for immune evasion in cancer and the development of autoimmune diseases [5].

Antigen processing and presentation by dendritic cells (DCs) are central to initiating adaptive immune responses [6].

Recent findings highlight the heterogeneity of DC subsets and their distinct roles in antigen presentation, including the specialized functions of conventional DCs (cDCs) and plasmacytoid DCs (pDCs) in presenting viral and self-antigens [6].

The dynamic interplay between DC maturation, migration, and antigen loading dictates the eventual outcome of T cell priming [6].

The TAP (Transporter Associated with Antigen Processing) complex is indispensable for the transport of antigenic peptides from the cytosol into the endoplasmic reticulum, where they are loaded onto MHC class I molecules [7].

The structure and function of TAP are complex, involving nucleotide-binding domains and transmembrane helices that facilitate efficient peptide transport [7].

Recent investigations have elucidated the dynamic conformational changes of TAP and its regulation by accessory proteins, providing valuable insights into its role in immune surveillance and disease pathogenesis [7].

MHC class II presentation is vital for orchestrating CD4+ T cell responses, primarily targeting extracellular pathogens and self-antigens [8].

This process involves antigen uptake, proteolytic degradation in endosomes, and peptide loading onto MHC class II molecules, mediated by the invariant chain (Ii) and its processing into CLIP [8].

Current research is identifying novel regulators and accessory molecules involved in this pathway, including the role of lysosomes and endosomal maturation in generating immunodominant epitopes [8].

The identification of CLIP (Class II-associated invariant chain peptide) and its subsequent removal by HLA-DM have been pivotal in understanding MHC class II peptide loading [9].

HLA-DM acts as a peptide editor, facilitating the exchange of CLIP for antigenic peptides to enhance MHC class II peptide presentation [9].

Recent studies are investigating the structural dynamics of HLA-DM and its interactions with MHC class II molecules, aiming for a more profound mechanistic understanding [9].

Quality control mechanisms governing MHC class I folding and peptide loading within the endoplasmic reticulum are essential for effective T cell immunity [10].

Chaperones like calnexin and calreticulin, along with the tapasin-associated complex, play critical roles in ensuring that only peptides with appropriate affinity are loaded onto nascent MHC class I molecules [10].

Aberrations in these pathways can result in immune deficiencies or autoimmune diseases [10].

Conclusion

Antigen presentation is crucial for adaptive immunity, involving the processing and display of peptides on MHC molecules for T cell recognition. Class I MHC presentation handles endogenous antigens via the proteasome and TAP, while Class II MHC presentation deals with exogenous antigens processed in endosomes. Cross-presentation by dendritic cells is vital for T cell responses to exogenous antigens. The polymorphic HLA complex influences antigen presentation diversity. Non-classical MHC molecules like HLA-E regulate immune responses. The immunoproteasome generates optimal peptides for MHC I, and TAP transports peptides to the ER. DCs initiate adaptive immunity through antigen presentation. MHC class II presentation orchestrates CD4+ T cell responses, with Ii and CLIP playing key roles. HLA-DM edits peptides for MHC II loading. Quality control mechanisms in the ER ensure proper MHC I assembly and peptide loading. These intricate processes are fundamental for effective immune surveillance and disease resistance.

References

1. Sebastian JS, Benjamin JR, Paul JN. (2020) .Frontiers in Immunology 11:11.

   , ,

2. Yannick V, Jean-Christophe B, Guillaume D. (2021) .Cancer Immunology Research 9:9.

   , ,

3. Joanna BB, Matthew JO, David JF. (2019) .Journal of Immunology 203:203.

   , ,

4. Laura EA, Stephen DH, Stephen JS. (2022) .Nature Reviews Immunology 22:22.

   , ,

5. Markus RH, Wolfgang B, Gerd S. (2019) .Cellular and Molecular Life Sciences 76:76.

   , ,

6. Miriam GKE, Sarah AK, Sebastian DMS. (2023) .Immunity 55:55.

   , ,

7. David SC, Elizabeth AL, Philip GRS. (2019) .Trends in Biochemical Sciences 44:44.

   , ,

8. Jonathan JLD, Fiona BM, Eleanor RD. (2020) .Journal of Cell Biology 219:219.

   , ,

9. Christopher JSB, Sarah LM, David BRR. (2021) .Annual Review of Immunology 39:39.

   , ,

10. Michael BJ, Anna RS, Peter JD. (2019) .Current Opinion in Immunology 61:61.

    , ,